| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.42 | 0.1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.2 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.2 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.07 | 0.2 |